ExpressGraft-C9T1 Skin Tissue

BIOLOGICAL2 trials

Sponsors

Stratatech, a Mallinckrodt Company

Conditions

DiabetesDiabetic Foot UlcerNon-healing Wound

Phase 1

ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers

CompletedNCT02657876

Stratatech, a Mallinckrodt CompanyDiabetes, Diabetic Foot Ulcer, Non-healing Wound

Start: 2018-01-31End: 2019-05-28Updated: 2019-10-15

Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot Ulcers

TerminatedNCT04134143

Stratatech, a Mallinckrodt CompanyDiabetes, Diabetic Foot Ulcer, Non-healing Wound

Start: 2019-11-07End: 2020-12-30Updated: 2021-01-14